LPL Financial
INFI

LPL Financial’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

LPL Financial’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-118,388
Closed -$75K – 4549
2022
Q2 		$75K Sell
118,388
-41,568
-26% -$31.9K ﹤0.01% 4183
2022
Q1 		$182K Buy
159,956
+20,604
+15% +$24.6K ﹤0.01% 3851
2021
Q4 		$314K Sell
139,352
-30,408
-18% -$76.3K ﹤0.01% 3653
2021
Q3 		$581K Buy
+169,760
New +$523K ﹤0.01% 3078

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LPL Financial's INFI Position: Q3 2022 in Review

LPL Financial sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 118,388 shares — an estimated $75K sold.

LPL Financial first reported a position in INFI in Q3 2021 and held it in 4 quarters. The position peaked at $581K in Q3 2021. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • LPL Financial reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • LPL Financial sold 118,388 Infinity Pharmaceuticals, Inc. shares in Q3 2022, an estimated $75K.
  • LPL Financial first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 4 quarters.
  • LPL Financial's Infinity Pharmaceuticals, Inc. position peaked at $581K in Q3 2021.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on LPL Financial's 13F filing for Q3 2022, filed 14 Nov 2022.